chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was reported.   This case was linked to MOD-2021-418891 (Patient Link).
Initial physician report received on 29 Dec 2010: The patient received MENVEO (batch number 10022), 0.5 ml, intramuscularly, on 14 Dec 2010. The patient experienced redness, swelling and pain at injection site, on 14 Dec 2010. The outcome of event was completely recovered on 16 Dec 2010. Follow-up report received from physician on 10 Jan 2011: Patient demographic updated. This patient received MENVEO (batch number 100022) 0.5 ml in left deltoid on 14 Dec 2010.
Tachycardia began 2/5/21 around 4:00pm and continued through 2/6/21 around 10:00pm. Shortness of breath and dizziness accompanied premature ventricular contractions from 2/6/21 around 6:00am through to 2/6/21 around 7:00pm. Severity was never such that I felt I needed to vagal. But symptoms were the most they had ever been.
patient looked tired 1 min after receiving the vaccine , provided pt with a lollipop to raise his blood sugar and water to keep him hydrated
EMPLOYEE STATED THAT SUDDENLY SHE JUST STARTED FEELING NAUSEATED AND LIGHT HEADED.
Information has been received from a doctor of pharmacy concerning a female patient, who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # not reported). The pharmacist reported that the patient's eye area was red. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Redness and rash around eyes approx 2 hours post immunization. BENADRYL susp. by mouth every 6 hours.
Golf ball size swelling; Red with bumps; Could not sleep night of vaccination; Severe flu symptoms; Right and left shoulders hurt; both shots on right shoulder; Left are and leg go num
Extreme fatigue onset after 2-3 days, difficulty staying awake/alert. Blurry vision & twitching eyes. Have difficulty being able to focus vision on close text & objects, and I'm a photographer who works through a camera and views a computer screen every day, so has been affecting my business. Have tried basic eye drops, but that doesn't help. Leg and upper/lower back muscles are extremely sore, even to the touch, especially upper leg muscles (and have not done any strenuous activities in the past week), and it's been painful to stand up or get out of my vehicle most of the time since my 1st shot exactly one week ago. Have also been having very bizarre dreams every night, and trouble sleeping, as well as bouts of hot/cold flashes every day. No cough, runny nose, headache, or other cold symptoms. Have never felt like this before, regret getting this vaccine, and am not sure I'll take the 2nd one, unfortunately. I have two close friends who had the same shot, and whom didn't even feel safe driving for 2+ weeks because of their similar reactions with fatigue and brain fog.
March 31, 2021: 12:30pm: Headache and sore arm 3:30pm: Nausea and severe headache 4:30pm: Pain in joints and swelling in hands + headache continuing 7pm: Severe chills with temperature at 100.3 F + headache continuing 8:30pm: Abdominal pain and continuation of chills + headache. Quite a bit of abdominal gas  April 1, 2021: 12:30am: Chills subsided and temp raised to 100.5F. Joints still still and sore. 6:30am: Sore joints but body temp back down to 98.3F and body aches not as bad 8am: Minor traces of blood in stool 10am: Took 2 advil for headache and other body pains 12pm: No more traces of blood in stool 11am: Headache minimized and body aches greatly reduced
pt presents to the ED for fever/HA and body aches after receiving J&J COVID vaccine, states she is no longer febrile but is still experiencing body aches.
At moment of vaccination and after vaccination patient seems normal and stable. Then, 3 days after vaccination, the patient contacted the pharmacy for a consult because of possibility of a post vaccine reaction.  The patient indicated that later that day of vaccination, at night, she started feeling dizzy, with nausea and vomiting, making it for her impossible to get out of bed. The other day of vaccination, the area where Pneumovax 23 vaccine was administered (left deltoid) was swollen, red, and with pain. These symptoms last a few days as she stated.  She came to the pharmacy seeking for treatment for her arm and Benadryl 25mg capsules three times daily and Benadryl cream three times daily was dispensed. Patient was contacted few days later for monitoring and she did not responded. Then,  1 week later and she answered and she indicated that symptoms improved, she was fine and stable.
Headache, Fever, Diarrhea, Abdominal pain, Cough, PNEUMONIA.
Initial report was received from a health care professional on 10 March 2011. A female patient with no reported medical history, had received an intramuscular right deltoid injection of ADACEL, lot number U3872BA (Sanofi Pasteur Ltd. lot number C3827) on Thursday 03March 2011. The patient had no reported reaction until Monday 07 March 2011. The patient was "seen" and diagnosed with cellulitis (date not reported). She was administered ROCEPHIN. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
blood immunoglobulin g: over 2500 on did an IG test and had over 2500 on unspecified date; Medical Information Potential AE; Tinnitus and hears a song in her head/a lot of ringing in the ears; inflammation; scar tissue in the lungs; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 08Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19 from Jan2021 to an unknown date, asthma from an unknown date and unknown if ongoing asthma worsened treated with Prednisone starting on Day 6 and changed to Dexamethasone on Day 10 , rash from an unknown date and unknown if ongoing She experienced a rash , vein rupture from an unknown date and unknown if ongoing She experienced bulging veins , dyspnoea from an unknown date and unknown if ongoing.On day 5 during the time caller had Covid Virus caller couldn't breathe , tinnitus from an unknown date and unknown if ongoing she is getting a lot of ringing in the ears and had the ringing in ears before. The patient's concomitant medications were not reported. The patient previously took prednisone, dexamethasone. The patient experienced medical information potential ae on an unspecified date, scar tissue in the lungs on 2021, tinnitus and hears a song in her head/a lot of ringing in the ears on 2021, inflammation on 2021. The patient underwent lab tests and procedures which included blood immunoglobulin g: over 2500 on did an IG test and had over 2500 on unspecified date. The outcome of the events adverse event NOS, pulmonary fibrosis, tinnitus, inflammation was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported. We are unable to perform follow-up to request batch/lot numbers.  No concomitant medications were reported. On 11-MAR-2021, the subject experienced migraine headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from migraine headache. The reporter considered the causality between covid-19 vaccine ad26.cov2.s and migraine headache as not related. This report was non-serious.  Version created to amend previously reported information on 11-MAR-2021. Upon review, following information was amended: The reporter causality has been updated from possible to non related and updated same in narrative.
We have some past expiration administrations that have surfaced; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some past expiration administrations that have surfaced) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 immunisation.     No Medical History information was reported.    In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some past expiration administrations that have surfaced). In 2021, EXPIRED PRODUCT ADMINISTERED (We have some past expiration administrations that have surfaced) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Event happened 6 months ago. No concomitant medication were given. No treatment information were given.
TIA, minor just one day only lasting stroke; This is a spontaneous report received from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN6206) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had an adverse reaction to the vaccine within a couple of days. TIA, minor just one day only lasting stroke. If symptoms are only within 24 hours its not a stroke its a TIA. Outcome of event was unknown.
Started experiencing  redness, swelling  and area is hot to the touch on 01/16 10 days after the shot. And still experiencing it going on the 5th day now
Headache & NauseaVomiting Narrative:  3 pm received vaccine on 1/20/21, woke up this am very nauseated, moderate headache, self care at home with ibuprofen as needed . Reports feeling better 1/21/21
2 DAYS AFTER RECEIVING VACCINES(11/15/08), PT DEVELOPED SOME SWELLING OF BOTH EYES AND SLIGHT RASH WITH SOME SWELLING IN SCROTUM.  ON 11/16/08, BOTH EYES WERE ALMOST COMPLETELY SWOLLEN SHUT AND SWELLING IN SCROTUM AND RASH WORSENED.  PT SEEN BY PVT MD ON 11/17 WHO PRESCRIBED BENADRYL AND MEDROL DOSE PACK.
HARD SPOT AT INJECTION SITE; HOT AROUND INJECTION AREA; REDNESS AROUND INJECTION SITE; ARM PAIN AROUND INJECTION SITE; This spontaneous report received from a patient concerned an 81 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced hard spot at injection site, hot around injection area, redness around injection site, and arm pain around injection site. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from hard spot at injection site, redness around injection site, hot around injection area, and arm pain around injection site. This report was non-serious.
Pneumonia; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. The consumer reported similar events for 2 patients. This is 2nd of 2 reports. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pneumonia after receiving first dose. Reporter stated that a friend also got pneumonia after receiving first dose. Outcome of event was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021233471 Same reporter, drug, event and different patient
This case was reported by a physician and described the occurrence of raised welts in a 29-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline), TWINRIX.  Concurrent medications included Yasmin.  On 21 April 2010 the subject received unspecified dose of BOOSTRIX (unknown, unknown arm), 1st dose of TWINRIX (unknown, unknown arm).  On 22 April 2010, 24 hours after vaccination with BOOSTRIX, at an unspecified time after vaccination with TWINRIX, the subject experienced raised welts.  The physician reported the subject received both a BOOSTRIX and TWINRIX vaccines on 21 April 2010.  The actual sites of the injections were not documented.  The physician discussed this with a sales representative and believed BOOSTRIX was more likely to be "wheel" area on arm.  Tylenol and cold compress were prescribed as treatment.  At the time of reporting the event was unresolved.  The physician considered the event was probably related to vaccination with BOOSTRIX and TWINRIX.
Initial report received on 24 October 2011 from a physician. A 6-year-old male patient, who had no concurrent illnesses had received an intramuscular left deltoid injection of FLUZONE (lot number UH475AA) on 19 October 2011 and 3 days later experienced fever, sore throat, chills, and body aches that required a physician visit. The patient had a flu test that was positive for influenza A and he was started on TAMIFLU. The patient subsequently developed a hive like rash on the right ankle, both legs and trunk, and a severe cough that had started on 23 October 2011. It was noted the patient has medical history of asthma that is treated with PULMICORT and albuterol as needed, and an allergy to Penicillin. At the time of this report the patient had not recovered. Documents held by sender: None.
1:15 PM-Was called to the client's chair, she was pale, lips pale, became unresponsive to verbal commands as eased to the floor by staff. Her respirations were becoming more shallow and her heart rate was 160 + EMS requested STAT.  1:17 PM Was able to regain consciousness with wet compresses and verbal commands, she was breathing rapidly and shallow and complaining of hands becoming ridged and painful she commented she had never felt this way before. 1:20 PM Heart rate 120s+ respiratory rate increasing, remained painful hands cramping, 50 mg Benadryl given right arm IM at 1:28 PM. She responded quickly with good respiratory effort and decrease pain cramping in her hands.   1:48 PM EMS arrives, the exam is done by EMT- O2 SAT 100s, Heart Rate 80 Respirations 20 B/P 120/60. The client denies feeling ill enough to go to ER, Refuses. ER Precautions are given to the client. She was escorted to her auto, instructed not to drive for 24 hours, and to see personal MD within 10 days of the vaccine.  Escorted to auto, she was able to ambulate well without assistance.
This is a spontaneous report from a contactable consumer who reported on behalf of her 5-year-old son. This consumer also reported similar events on her daughter, the twin of this patient. This is the second of the two reports. The patient received the first dose of PREVNAR on 06Jul2005 at the age of 2 months. The patient received the last dose of PREVNAR injection in Jul2006 at the age of 14 months, thus completing the therapy regimen. The number of total doses received was unknown. Relevant medical history was none. Relevant concomitant medications were none. Vaccines given on the same day was unknown. At the age of 5 years, in Feb2011 and on 10Mar2011 he was diagnosed with community acquired pneumonia. Therapeutic measure taken as a result of community acquired pneumonia included treatment with ZITHROMAX. Relevant lab data was none. At the time of the report he had not recovered from community acquired pneumonia. Follow-up (28APR2011): Follow-up attempts completed. No further information expected.
I reimmunized this patient with Fluzone ID after discovering that a significant amount of the vaccine did not get injected.
Patient experienced myalgia all over his body and fleeting dizziness. Dizziness lasted couple of seconds; patient did not have any symptoms of a local reaction. Follow up obtained on 04/08/09; Patient's doctor presumes that patient recovered as he did not come back for follow up appointment and did not return calls from the doctor's office.
Site: Redness at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Fever-Medium
Pt recvd vax JUN92 & devel burning sensation upon inject as well as soreness & for an aching sensation in the arm; heaviness in the arm also;
her feet are all swelled up/her left arm swelled up too; She has lost memory; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jul2021 (Lot number: FA7458) at the age of 65 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "anemic" (unspecified if ongoing), notes: that one she has had all her life.; "bad bladder and cannot hold her pee/ peeing on herself" (unspecified if ongoing), notes: Started 25 years ago. Concomitant medication(s) included: OXYBUTIN taken for hypertonic bladder. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset Jul2021, outcome "not recovered", described as "her feet are all swelled up"; AMNESIA (non-serious) with onset Jul2021, outcome "unknown", described as "She has lost memory".  Additional information: Patient's husband reported  that after receiving the vaccine, patient's feet were all swelled up. The patient was handicapped and has been for 20 years. Reporter is her guardian and takes care of her. She has lost memory and never had lost memory before getting the vaccine. She was anemic and that one she has had all her life. Reporter provided her name as withheld and she has the same address and phone as him. Reporter stated her feet swelled up same date his symptoms started, which was 2 weeks ago and said they look bad. Caller said his wife's feet swelled up and never went down, she put ice on it and it never went down. Reporter also said her left arm swelled up too. It started two weeks ago. The patient took Oxybutin 10mg for her bladder and told pharmacy that too before getting the vaccination, they said it would not be a problem. The patient has been on oxybutin for 25 years. The reporter wanted Pfizer to compensate both he and his girlfriend for what has happened.  No follow-up attempts are possible. No further information is expected.
After second Moderna shot, Pt developed nausea, headache, extreme fatique, and bad back and leg cramps/spasms to the point where he couldn't walk.  These symptoms lasted for 48 hours and gradually subsided.  His wife (me) was so frightened that I will not be getting the Moderna series since it's so dangerous and will caution friends and family as well.
One week after Moderna vaccine,  an ipsilateral  tender supraclavicular lymph node developed.
chills; high grade fever (T-39.9C); muscle ache; weakness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (high grade fever (T-39.9C)), MYALGIA (muscle ache) and ASTHENIA (weakness) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (high grade fever (T-39.9C)), MYALGIA (muscle ache) and ASTHENIA (weakness). On 01-Mar-2021, CHILLS (chills) and PYREXIA (high grade fever (T-39.9C)) had resolved. At the time of the report, MYALGIA (muscle ache) and ASTHENIA (weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not reported  Treatment information was not provided   This case was linked to MOD-2021-030562 (E2B Linked Report).; Sender's Comments:  MOD-2021-030562:crosslink
pt recv 2 doses of vax SEP & NOV95 & lab eval revealed varicella IgG 0.10;
Death within 60 days of vaccination.  Unwitnessed cardiac arrest, CPR attempted and unsuccessful.
10 1/2 hrs p/DTP/OPV, pt exp a sz (generalized tonic-clonic) @ home; event reported by mom; no tx initiated; t100.3 ax; pt has no prior hx of seizures; pt recovered;
Development of numbness in face within hours of vaccination.  Symptoms progressed within 24 hours to include burning feeling in the body, ear ringing, change in personality, sensitive to bright lights and loud noises, difficulty understanding conversations.
Patient recieved vaccine after being in fridge for more than 31 days. Exacltly 24.5 hours afterwards.
yesterday just a sore arm which is normal/woke up with sore muscles; Initial information received on 10-Nov-2020 regarding an unsolicited valid non-serious social media case received from a consumer (Patient).  This case involved adult patient who had yesterday just a sore arm which is normal/woke up with sore muscles (Myalgia), while patient received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient had yesterday just a sore arm which is normal/woke up with sore muscles (Myalgia), unknown latency following the administration of INFLUENZA VACCINE.  No relevant laboratory data was reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown, at the time of reporting.  There will be no information available on the batch number for this case.